NCT01485601View on ClinicalTrials.gov

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

PHASE2CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

December 7, 2011

Primary Completion Date

March 30, 2012

Study Completion Date

August 17, 2012

Conditions
Glabellar Frown Lines
Interventions
BIOLOGICAL

MT10109

Single dose intramuscular injection MT10109 vs Botox®

Trial Locations (1)

Unknown

Melbourne

All Listed Sponsors
lead

Medy-Tox

INDUSTRY

NCT01485601 - Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines | Biotech Hunter | Biotech Hunter